Royalty Pharma plc (NASDAQ: RPRX) is 28.77% higher on its value in year-to-date trading and has touched a low of $24.05 and a high of $32.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RPRX stock was last observed hovering at around $32.36 in the last trading session, with the day’s gains setting it 0.49%.
Currently trading at $32.85, the stock is 3.96% and 15.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.0 million and changing 1.51% at the moment leaves the stock 18.74% off its SMA200. RPRX registered 12.12% gain for a year compared to 6-month gain of 19.85%.
The stock witnessed a 6.14% loss in the last 1 month and extending the period to 3 months gives it a 27.08%, and is 3.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.66% over the week and 1.94% over the month.
Royalty Pharma plc (RPRX) has around 99 employees, a market worth around $18.94B and $2.26B in sales. Current P/E ratio is 17.13 and Fwd P/E is 6.57. Profit margin for the company is 37.93%. Distance from 52-week low is 36.59% and -0.12% from its 52-week high. The company has generated returns on investments over the last 12 months (6.33%).
The EPS is expected to grow by 13.00% this year.
Royalty Pharma plc (RPRX) Top Institutional Holders
The shares outstanding are 445.99M, and float is at 372.09M with Short Float at 4.33%.
The top institutional shareholder in the company is MORGAN STANLEY with over 44.13 million shares valued at $1.16 billion. The investor’s holdings represent 9.8375% of the RPRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 38.02 million shares valued at $1.0 billion to account for 8.4754 of the shares outstanding. The other top investors are FMR LLC which holds 27.89 million shares representing 6.2161% and valued at over $735.37 million, while BLACKROCK INC. holds 5.1307 of the shares totaling 23.02 million with a market value of $606.97 million.
Royalty Pharma plc (RPRX) Insider Activity
#####
